Related references
Note: Only part of the references are listed.Targeting of nanoparticles in cancer: drug delivery and diagnostics
Meghna Talekar et al.
ANTI-CANCER DRUGS (2011)
Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis
Michael E. Werner et al.
BIOMATERIALS (2011)
Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery
Yanhua Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Development of EGFR-Targeted Polymer Blend Nanocarriers for Combination Paclitaxel/Lonidamine Delivery To Treat Multi-Drug Resistance in Human Breast and Ovarian Tumor Cells
Lara Milane et al.
MOLECULAR PHARMACEUTICS (2011)
A preferential p110α/γ PI3K inhibitor attenuates experimental inflammation by suppressing the production of proinflammatory mediators in a NF-κB-dependent manner
Nilesh M. Dagia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Folate-Receptor-Targeted Delivery of Doxorubicin Using Polyethylene Glycol-Functionalized Gold Nanoparticles
Bahareh Asadishad et al.
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH (2010)
Curcumin Enhances Oral Bioavailability and Anti-Tumor Therapeutic Efficacy of Paclitaxel upon Administration in Nanoemulsion Formulation
Srinivas Ganta et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Phosphoinositide-3-kinase (PI3K) inhibitors: Identification of new scaffolds using virtual screening
Raphael Frederick et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells
Srinivas Ganta et al.
MOLECULAR PHARMACEUTICS (2009)
Epidermal Growth Factor Receptor-Targeted Gelatin-Based Engineered Nanocarriers for DNA Delivery and Transfection in Human Pancreatic Cancer Cells
Padmaja Magadala et al.
AAPS JOURNAL (2008)
Targeting phosphoinositide 3-kinase - Moving towards therapy
Romina Marone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Class IA phosphatidylinositol 3-kinase: from their biologic implication in human cancers to drug discovery
Sauveur-Michel Maira et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo
Shuxian Song et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion
Srinivas Ganta et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate
Farnaz Esmaeili et al.
JOURNAL OF DRUG TARGETING (2008)
Selective delivery of folate-PEG-linked, nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft: Effect of chain length and amount of folate-PEG linker
Yukino Ohguchi et al.
JOURNAL OF DRUG TARGETING (2008)
A nanoemulsion formulation of tamoxifen increases its efficacy in a breast cancer cell line
Jean-Bosco Tagne et al.
MOLECULAR PHARMACEUTICS (2008)
Nanoemulsion Preparations of the Anticancer Drug Dacarbazine Significantly Increase Its Efficacy in a Xenograft Mouse Melanoma Model
Jean-Bosco Tagne et al.
MOLECULAR PHARMACEUTICS (2008)
Biodistribution and pharmacokinetic analysis of paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model
Lilian E. van Vlerken et al.
MOLECULAR PHARMACEUTICS (2008)
Taming the PI3K team to hold inflammation and cancer at bay
Emilio Hirsch et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110α inhibitors
Jackie D. Kendall et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer
Harikrishna Devalapally et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110α inhibitors
Masahiko Hayakawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling
Claire Chaussade et al.
BIOCHEMICAL JOURNAL (2007)
Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer
Lilian E. van Vlerken et al.
CANCER RESEARCH (2007)
Rare cancer-specific mutations in PIK3CA show gain of function
Marco Gymnopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Improved oral delivery of paclitaxel following administration in nanoemulsion formulations
Sandip B. Tiwari et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2006)
A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling
Zachary A. Knight et al.
CELL (2006)
A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization
JD Orth et al.
CANCER RESEARCH (2006)
Mutation of the PIK3CA oncogene in human cancers
B Karakas et al.
BRITISH JOURNAL OF CANCER (2006)
Cancer-specific mutations in PIK3CA are oncogenic in vivo
AG Bader et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nanoemulsion
Ana C. Lo Prete et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
A pharmacological map of the PI3-K family defines a role for p110 alpha in insulin signaling
Zachary A. Knight et al.
CELL (2006)
Ceramide involvement in apoptosis and apoptotic diseases
Karin Thevissen et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics
ZH Li et al.
FASEB JOURNAL (2005)
Disposition characteristics of emulsions and incorporated drugs after systemic or local injection
S Kawakami et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
Share Paper
